Tag: NASDAQ CNSP

Business

CNS Pharmaceutical Inc. (NASDAQ: CNSP) Offers Updates On Development of Berubicin in Treating GBM

CNS Pharmaceutical Inc. (NASDAQ: CNSP) announced its business update, including the recent launch of a pivotal study of its flagship program assessing Berubicin in adult Glioblastoma Multiforme (FB) treatment and expects to commence dosing in Q3 2021.¬† Berubicin receives Fast Track Designation¬† The company received Fast track Designation for Berubicin […]